2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Haugen, Bryan R., Alexander, Erik K., Bible, Keith C., Doherty, Gerard M., Mandel, Susan J., Nikiforov, Yuri E., Pacini, Furio, Randolph, Gregory W. +8 more·2016·Thyroid®

Cites (1,326)

Items 1,001–1,200 of 1,326

  1. Hepatitis-B surface antigen and hepatocellular carcinoma in Taiwan. With special reference to types and localization of HBsAg in the tumor cells
    Hey‐Chi Hsu, Wen-Shih-Jen Lin, Ming-Ju Tsai · 1983 · Cancer
  2. BRAF status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence
    Jason D. Prescott, Peter M. Sadow, Richard A. Hodin, Long P. Le, Randall D. Gaz, Gregory William Randolph, Antonia E. Stephen, Sareh Parangi, Gilbert H. Daniels, Carrie Cunningham Lubitz · 2012 · Surgery
  3. Clinical and Ultrasonographic Findings Affecting Nondiagnostic Results upon the Second Fine Needle Aspiration for Thyroid Nodules
    Yoon Seong Choi, Soon Won Hong, Jin Young Kwak, Hee Jung Moon, Eun‐Kyung Kim · 2012 · Annals of Surgical Oncology
  4. Predictive Value of Serum Thyroglobulin After Surgery for Thyroid Carcinoma
    Francis T. Hall, Nigel J P Beasley, Spiro J. Eski, Ian Witterick, Paul G. Walfish, Jeremy L. Freeman · 2003 · The Laryngoscope
  5. Moderate Hypothyroidism in Preparation for Whole Body 131 I Scintiscans and Thyroglobulin Testing
    Valéria C. Guimarães, Leslie J. DeGroot · 1996 · Thyroid
  6. Rapid Rise in Serum Thyrotropin Concentrations after Thyroidectomy or Withdrawal of Suppressive Thyroxine Therapy in Preparation for Radioactive Iodine Administration to Patients with Differentiated Thyroid Cancer
    Dina I. Serhal, Mona Nasrallah, Baha M. Arafah · 2004 · The Journal of Clinical Endocrinology & Metabolism
  7. Should the thyroid AUS/FLUS category be further stratified by malignancy risk?
    Michiya Nishino, Helen H. Wang · 2014 · Cancer Cytopathology
  8. Benign thyroid disease and vocal cord palsy.
    Julian Rowe‐Jones, R P Rosswick, S. E. J. Leighton · 1993 · PubMed
  9. Extrathyroidal Extension Predicts Extranodal Extension in Patients with Positive Lymph Nodes: An Important Association That May Affect Clinical Management
    Jason B. Clain, Sophie Scherl, Laura L. Dos Reis, Andrew T. Turk, Bruce M. Wenig, Saral Mehra, William E. Karle, Mark L. Urken · 2014 · Thyroid
  10. Serum thyroglobulin concentrations and (131)I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone.
    Alessia David, Annabella Blotta, Marta Bondanelli, R Rossi, E. Roti, Lewis E. Braverman, Luciano Busutti, Ettore C. degli Uberti · 2001 · PubMed
  11. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high‐dose total body scan are not reliable criteria for cure after radioiodine treatment
    Anne Bachelot, Sophie Leboulleux, Éric Baudin, Dana M. Hartl, Bernard Caillou, Jean‐Paul Travagli, Martin Jean Schlumberger · 2005 · Clinical Endocrinology
  12. Antithyroglobulin antibodies in patients with differentiated thyroid carcinoma: methods of detection, interference with serum thyroglobulin measurement and clinical significance
    Pedro Weslley Rosário, Frederico Fernandes Ribeiro Maia, Tales Alvarenga Fagundes, Flávio P.J. Vasconcelos, Ludmilla David Cardoso, Saulo Purisch · 2004 · Arquivos Brasileiros de Endocrinologia & Metabologia
  13. Staging Systems for Papillary Thyroid Carcinoma
    Brian Hung‐Hin Lang, Sin‐Ming Chow, Chung‐Yau Lo · 2007 · Annals of Surgery
  14. Compassionate Use of Recombinant Human Thyrotropin to Facilitate Radioiodine Therapy: Case Report and Review of Literature
    Richard J. Robbins, Emily Voelker, Weiping Wang, Homer A. Macapinlac, Steven M. Larson · 2000 · Endocrine Practice
  15. Reoperative Lymph Node Dissection for Recurrent Papillary Thyroid Cancer and Effect on Serum Thyroglobulin
    David T. Hughes, Amanda M. Laird, Barbra S. Miller, Paul G. Gauger, Gerard M. Doherty · 2012 · Annals of Surgical Oncology
  16. Radioactive Iodine Therapy Decreases Recurrence in Thyroid Papillary Microcarcinoma
    Kimberly M. Creach, Barry Alan Siegel, Brian A. Nussenbaum, Perry W. Grigsby · 2012 · ISRN Endocrinology
  17. Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake
    Pedro Weslley Rosário, Janice Sepúlveda Reis, Álvaro Luís Barroso, Leonardo Lamego Rezende, Eduardo Lanza Padrao, Tales Alvarenga Fagundes · 2004 · Nuclear Medicine Communications
  18. Thyroid fine needle aspiration cytology: a review of the National Cancer Institute state of the science symposium
    Lester James Layfield, Edmund S. Cibas, Zubair Wahid Baloch · 2010 · Cytopathology
  19. Molecular Markers in Thyroid Fine-needle Aspiration Biopsy
    Carmen Franco, Virginia Martínez, J Allamand, Francisco Medina, Andrea Glasinovic P., Miren Osorio, Dina Schächter · 2009 · Applied immunohistochemistry & molecular morphology
  20. The Locality Rule and the Physician's Dilemma
    Michelle Lewis, John K. Gohagan, Daniel J. Merenstein · 2007 · JAMA
  21. Role of metastasectomy in the management of thyroid carcinoma: The NIH experience
    Ho Pak, Loukas Gourgiotis, Wen‐I Chang, Lori C. Guthrie, Monica C. Skarulis, James C. Reynolds, Maria J. Merino, David S. Schrump, Steven K. Libutti, Henry Richard Alexander et al. · 2002 · Journal of Surgical Oncology
  22. Routine second-opinion cytopathology review of thyroid fine needle aspiration biopsies reduces diagnostic thyroidectomy
    Tomer Davidov, Stanley Zackary Trooskin, Beth‐Ann Shanker, Dana T. Lin, Oliver S. Eng, Jessica S. Crystal, Jun Hu, Victoriya S. Chernyavsky, Malik F. Deen, Michael May et al. · 2010 · Surgery
  23. The Rate of Tumour Growth Does Not Distinguish Between Malignant and Benign Thyroid Nodules
    Shinya Kobayashi Kazuhiko Asanuma · 2001 · The European Journal of Surgery
  24. Prognostic value of post-thyroidectomy thyroglobulin levels in patients with differentiated thyroid cancer.
    Ari Polachek, Dania Hirsch, Gloria Tzvetov, Simona Grozinsky‐Glasberg, I. Slutski, Joelle Singer, Ruth Weinstein, Ilan Shimon, Carlos A. Benbassat · 2011 · PubMed
  25. Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma
    Luca Giovanella, Luca Ceriani, Antonella Ghelfo · 2005 · Clinical Chemistry and Laboratory Medicine (CCLM)
  26. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?
    Nathan W. Hales, Greg A. Krempl, Jesús E. Medina · 2008 · American Journal of Otolaryngology
  27. Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer
    Catharina Ihre Lundgren, Per N Hall, Paul William Dickman, Jan Zedenius · 2007 · British journal of surgery
  28. Individualized dosimetry in the management of metastatic differentiated thyroid cancer.
    Carlo Chiesa, Maria Rita Castellani, Cecilia Vellani, Eva Orunesu, A. Negri, Raffaella Azzeroni, Francesca Botta, Marco Maccauro, Gianluca Aliberti, Ettore Cesare Seregni et al. · 2009 · PubMed
  29. Modified Radical Neck Dissection for Differentiated Thyroid Cancer: Operative Technique
    Shinya Uchino, Shiro Noguchi, Hiroyuki Yamashita, Shin Watanabe · 2004 · World Journal of Surgery
  30. Cystic change in thyroid carcinoma: Prevalence and estimated volume in 360 carcinomas
    Tara L. Henrichsen, Carl C. Reading, J. William Charboneau, Daniel J. Donovan, Thomas J. Sebo, IAN D. HAY · 2010 · Journal of Clinical Ultrasound
  31. The Importance of Pre- and Postoperative Laryngeal Examination for Thyroid Surgery
    Gregory William Randolph · 2010 · Thyroid
  32. Patient’s comfort with and tolerability of thyroid core needle biopsy
    Naim Nasrollah, Pierpaolo Trimboli, Fabio Rossi et al. · 2013 · Endocrine
  33. Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl
    Helge U. Hebestreit, Johannes Biko, Валентина Дрозд · 2011 · European Journal of Nuclear Medicine and Molecular Imaging
  34. Evaluation and Treatment of Aerodigestive Tract Invasion by Well-Differentiated Thyroid Carcinoma
    Judith Czaja McCaffrey · 2000 · Cancer Control
  35. Higher Administered Activities of Radioactive Iodine Are Associated with Less Structural Persistent Response in Older, but Not Younger, Papillary Thyroid Cancer Patients with Lateral Neck Lymph Node Metastases
    Mona M. Sabra, Ravinder K. Grewal, Ronald A. Ghossein, Robert Michael Tuttle · 2014 · Thyroid
  36. Undetectable Sensitive Serum Thyroglobulin (<0.1 ng/ml) in 163 Patients with Follicular Cell-Derived Thyroid Cancer: Results of rhTSH Stimulation and Neck Ultrasonography and Long-Term Biochemical and Clinical Follow-Up
    Ana Maria Chindriş, Nancy N. Diehl, Julia E. Crook, Vahab Fatourechi, Robert C. Smallridge · 2012 · The Journal of Clinical Endocrinology & Metabolism
  37. Undetectable Thyroglobulin in Patients With Differentiated Thyroid Carcinoma and Residual Radioiodine Uptake on a Postablation Whole-Body Scan
    Luca Giovanella, Sergio Suriano, Luca Ceriani, Frederik A. Verburg · 2011 · Clinical Nuclear Medicine
  38. Is there a role for radiation therapy in the management of hürthle cell carcinoma?
    Robert L. Foote, Paul D. Brown, Yolanda I. Garces, Bryan McIver, Jan L. Kasperbauer · 2003 · International Journal of Radiation Oncology*Biology*Physics
  39. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: Is thyroid lobectomy the treatment of choice for low-risk patients?
    Aya Ebina, Iwao Sugitani, Yoshihide Fujimoto, Keiko Yamada · 2014 · Surgery
  40. Prognostic value of an increase in the serum thyroglobulin level at the time of the first ablative radioiodine treatment in patients with differentiated thyroid cancer
    Marie‐Odile Bernier, Olivier Morel, Patrice Rodien · 2005 · European Journal of Nuclear Medicine and Molecular Imaging
  41. Development of a clinical decision model for thyroid nodules
    Alexander Stojadinovic, George Earl Peoples, Steven K. Libutti, Leonard R. Henry, John S. Eberhardt, Robin S Howard, David Gur, Eric Andrew Elster, Aviram Nissan · 2009 · BMC Surgery
  42. The impact of initial surgical management on outcome in young patients with differentiated thyroid cancer
    Daniel K. Robie, Catherine Dinauer, Robert Michael Tuttle, David T. Ward, Robert Parry, Donald R McClellan, Rita L. Svec, Carol Adair, Gary L. Francis · 1998 · Journal of Pediatric Surgery
  43. The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131I
    Robbert B. T. Verkooijen, Marcel P. M. Stokkel, Johannes W. van Isselt · 2009 · Nuklearmedizin - NuclearMedicine
  44. The Cytological, Clinical, and Pathological Features of the Cribriform-Morular Variant of Papillary Thyroid Carcinoma and Mutation Analysis of CTNNB1 and BRAF Genes
    Chan Kwon Jung, Yeong Jin Choi, Kyo Young Lee, Ja Seong Bae, Hyung Jin Kim, Seung Kew Yoon, Young‐Ik Son, Jae Hoon Chung, Young Lyun Oh · 2009 · Thyroid
  45. Cost-Effectiveness of FDG-PET/CT for Cytologically Indeterminate Thyroid Nodules: A Decision Analytic Approach
    Dennis Vriens, Eddy Adang, Romana Teodora Netea-Maier, Johannes W. A. Smit, Johannes H. W. de Wilt, Wim J.G. Oyen, Lioe‐Fee de Geus‐Oei · 2014 · The Journal of Clinical Endocrinology & Metabolism
  46. Sequential Changes of Serum Antithyroglobulin Antibody Levels Are a Good Predictor of Disease Activity in Thyroglobulin-Negative Patients with Papillary Thyroid Carcinoma
    Ching‐Jung Hsieh, Pei‐Wen Wang · 2013 · Thyroid
  47. Diagnostic value of thyroglobulin assay in cervical lymph node fine-needle aspirations for metastatic differentiated thyroid cancer
    Luca Giovanella, Massimo Bongiovanni, Pierpaolo Trimboli · 2012 · Current Opinion in Oncology
  48. Autoimmune Thyroid Disease: A Risk Factor for Thyroid Cancer
    Ghobad Azizi, Carl D. Malchoff · 2010 · Endocrine Practice
  49. Thyroglobulin before Ablation and Correlation with Posttreatment Scanning
    Pedro Weslley Souza Ros rio, Val ria C. Guimar es, Frederico Fernandes Ribeiro Maia · 2005 · The Laryngoscope
  50. Outcome of Thyroid Nodules Characterized as Atypia of Undetermined Significance or Follicular Lesion of Undetermined Significance and Correlation With Ultrasound Features and BRAFV600E Mutation Analysis
    Sun Hye Jeong, Hyun Sook Hong, Eun Hye Lee, Jang Gyu Cha, Ji Sang Park, Jung Ja Kwak · 2013 · American Journal of Roentgenology
  51. Management of Differentiated Thyroid Cancer with Rising Thyroglobulin and Negative Diagnostic Radioiodine Whole Body Scan
    Chao Ma · 2010 · Clinical Oncology
  52. Lessons from Mouse Models of Thyroid Cancer
    Caroline S. Kim, Xuguang Zhu · 2009 · Thyroid
  53. Exclusion of Malignancy in Thyroid Nodules with Indeterminate Fine‐Needle Aspiration Cytology After Negative 18F‐Fluorodeoxyglucose Positron Emission Tomography: Interim Analysis
    Amber Linnell Traugott, Farrokh Dehdashti, Kathryn M. Trinkaus, Mark Steven Cohen, Elizabeth Fialkowski, Frank J. Quayle, Hameda B. Hussain, Rosa M. Dávila, Lourdes R. Ylagan, Jeffrey F. Moley · 2010 · World Journal of Surgery
  54. Impact of timing on completion thyroidectomy for thyroid cancer
    Mona Poh-Choo Tan, Gaurav Agarwal, T. S. Reeve, Bruce H. Barraclough, Leigh Delbridge · 2002 · British journal of surgery
  55. Empiric High-Dose 131-Iodine Therapy Lacks Efficacy for Treated Papillary Thyroid Cancer Patients with Detectable Serum Thyroglobulin, but Negative Cervical Sonography and 18F-Fluorodeoxyglucose Positron Emission Tomography Scan
    Won Gu Kim, Jin‐Sook Ryu, Eui Young Kim et al. · 2010 · The Journal of Clinical Endocrinology & Metabolism
  56. The Role of MR Imaging in Detecting Nodal Disease in Thyroidectomy Patients with Rising Thyroglobulin Levels
    Summer L. Kaplan, S. J. Mandel, R. Muller, Zafar Haleem Baloch, E.R. Thaler, Laurie A. Loevner · 2008 · American Journal of Neuroradiology
  57. Detection of Residual and Recurrent Thyroid Cancer by Radionuclide Imaging
    Harry R. Maxon · 1999 · Thyroid
  58. Multidisciplinary Treatment and Survival of Patients with Vertebral Metastases from Thyroid Carcinoma
    Gerald M. Y. Quan, Vincent Pointillart, Jean Palussière · 2011 · Thyroid
  59. Clinical Experience with Recombinant Human Thyrotrophin (rhTSH) in the Management of Patients with Differentiated Thyroid Cancer
    Giuliano Mariani, Marco Ferdeghini, Carla Augeri, Giuseppe Villa, Gioconda Z. Taddei, Giovanni Scopinarô, Giuseppe Boni, Lisa Bodei, C Rabitti, Ettore Molinari et al. · 2000 · Cancer Biotherapy and Radiopharmaceuticals
  60. Fine-needle aspiration of thyroid lesions in 57 pregnant and postpartum women
    Edith F. Marley, Yolanda C. Oertel · 1997 · Diagnostic Cytopathology
  61. THYROGLOBULIN OF VARYING MOLECULAR SIZES WITH DIFFERENT DISAPPEARANCE RATES IN PLASMA FOLLOWING SUBTOTAL THYROIDECTOMY
    Ulla Feldt‐Rasmussen, P H Petersen, Hans Jørgen Nielsen, John Date, Charlotte Madsen · 1978 · Clinical Endocrinology
  62. Incidental thyroid “PETomas”: clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake
    Hidefumi Nishimori, Roger J. Tabah, Marc P. Hickeson · 2011 · Canadian Journal of Surgery
  63. Medullary Thyroid Carcinoma
    Ana O. Hoff, Paulo M. Hoff · 2007 · Hematology/Oncology Clinics of North America
  64. Preparation for radioactive iodine administration in differentiated thyroid cancer patients
    Yair Liel · 2002 · Clinical Endocrinology
  65. Role of Sonographic Diagnosis in Managing Bethesda Class III Nodules
    Dong Wook Kim, E.J. Lee, Soo Jin Jung · 2011 · American Journal of Neuroradiology
  66. Total versus subtotal thyroidectomy. Arguments, approaches, and recommendations.
    Michael Friedman, Bernard L. Pacella · 1990 · PubMed
  67. The management of advanced thyroid cancer
    P. Wilson, Barbara-Ann M. Millar, James D. Brierley · 2004 · Clinical Oncology
  68. Comparison between ethanol sclerotherapy and emptying with injection of saline in treatment of thyroid cysts
    A. Antonelli, Alessandro Campatelli, A. Vito, BALDASSARE ALBERTI, V. Baldi, Giulio Salvioni, Pupah Fallahi, L. Baschieril · 1994 · Journal of Molecular Medicine
  69. Diagnostic Yield of Nondiagnostic Thyroid Nodules Is Not Altered by Timing of Repeat Biopsy
    Carrie Cunningham Lubitz, Sushruta S. Nagarkatti, William C. Faquin et al. · 2012 · Thyroid
  70. Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism.
    Matthew David Ringel, Paul W. Ladenson · 1996 · The Journal of Clinical Endocrinology & Metabolism
  71. Postsurgery serum thyroglobulin disappearance kinetic in patients with differentiated thyroid carcinoma
    Luca Giovanella, Luca Ceriani, Marco Maffioli · 2009 · Head & Neck
  72. Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18 000 FNAs reported at the same institution during 1998-2007
    Simonetta Piana, Andrea Frasoldati, Michele Ferrari · 2010 · Cytopathology
  73. Randomized Controlled Trial of a Computerized Decision Aid on Adjuvant Radioactive Iodine Treatment for Patients With Early-Stage Papillary Thyroid Cancer
    Anna M. Sawka, Sharon Elizabeth Straus, LORNE E. ROTSTEIN, James D. Brierley, Richard W. C. Tsang, Sylvia L. Asa, Phillip Segal, Catherine Margaret Kelly, Afshan Zahedi, Jeremy L. Freeman et al. · 2012 · Journal of Clinical Oncology
  74. Proceedings: Effect of a low iodine diet on 131-I therapy in follicular thyroid carcinomata.
    B. M. Goslings · 1975 · PubMed
  75. Heterophile Antibodies Rarely Influence the Measurement of Thyroglobulin and Thyroglobulin Antibodies in Differentiated Thyroid Cancer Patients
    Frederik A. Verburg, K. Wäschle, Christoph Reiners, Luca Giovanella, Eef G.W.M. Lentjes · 2010 · Hormone and Metabolic Research
  76. Is BRAF mutation associated with lymph node metastasis in patients with papillary thyroid cancer?
    Kathleen C. Lee, Carol Y. Li, Eric B. Schneider · 2012 · Surgery
  77. Natural course of benign thyroid nodules in a moderately iodine‐deficient area
    Murat Faik Erdoğan, Alptekin Gürsoy, Gürbüz Erdoğan · 2006 · Clinical Endocrinology
  78. Diagnostic values of thyroglobulin measurement in fine-needle aspiration of lymph nodes in patients with thyroid cancer
    Kyoungjune Pak, Sunghwan Suh, Hyunsook Hong, Gi Jeong Cheon, Seokyung Hahn, Keon Wook Kang, E. Edmund Kim, Dong Soo Lee, June Key Chung · 2014 · Endocrine
  79. Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for the thyroid nodules with indeterminate fine needle aspiration biopsy? a meta-analysis of the literature
    Ningjian Wang, Hualing Zhai, Yingli Lu · 2013 · Journal of Otolaryngology - Head and Neck Surgery
  80. Esophageal Invasion by Thyroid Carcinomas: Prediction Using Magnetic Resonance Imaging
    Jichen Wang, Shodayu Takashima, Tsuyoshi Matsushita, Fumiyoshi Takayama, Tetsuro Kobayashi, Masumi Kadoya · 2003 · Journal of Computer Assisted Tomography
  81. Differentiated Thyroid Carcinoma in Children and Young Adults: Evaluation of Response to Treatment
    Nir Hod, Philippe Hagag, Michal Baumer, Judith Sandbank, Tifha Horne · 2005 · Clinical Nuclear Medicine
  82. Pseudomonas aeruginosa bacteremia in patients with neoplastic disease
    Louis S. Fishman, Donald Armstrong · 1972 · Cancer
  83. The clinicopathological significance of histologic vascular invasion in differentiated thyroid carcinoma
    Toshirou Nishida, Shou-ichi Katayama, Masahiko Tsujimoto · 2002 · The American Journal of Surgery
  84. Children with Differentiated Thyroid Cancer Achieve Adequate Hyperthyrotropinemia within 14 Days of Levothyroxine Withdrawal
    Wichert J. Kuijt, Stephen A. Huang · 2005 · The Journal of Clinical Endocrinology & Metabolism
  85. BRAFV600E Mutation Analysis in Papillary Thyroid Carcinoma: Is it Useful for all Patients?
    Yasuhiro Ito, Hiroshi Yoshida, Minoru Kihara · 2013 · World Journal of Surgery
  86. Thyroidectomy‐Related Malpractice Claims
    Michael C. Singer, Kenneth Iverson, David James Terris · 2012 · Otolaryngology
  87. The Role of BRAFV600E Mutation and Ultrasonography for the Surgical Management of a Thyroid Nodule Suspicious for Papillary Thyroid Carcinoma on Cytology
    Hee Jung Moon, Jin Young Kwak, Eun‐Kyung Kim · 2009 · Annals of Surgical Oncology
  88. Usefulness of Recombinant Human Thyrotropin in the Radiometabolic Treatment of Selected Patients with Thyroid Cancer
    Gabriella Pellegriti, Claudia Scollo, Dario Giuffrida, Riccardo Vigneri, Sebastiano Squatrito, VINCENZO PEZZINO · 2001 · Thyroid
  89. Patients' experiences following local–regional recurrence of thyroid cancer: A qualitative study
    Shikha Misra, Soumia Meiyappan, Lineke Heus et al. · 2013 · Journal of Surgical Oncology
  90. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems
    Emin Yıldırım · 2005 · Journal of the American College of Surgeons
  91. Oncologic Outcomes After Completion Thyroidectomy for Patients with Well-Differentiated Thyroid Carcinoma
    Brian R. Untch, Frank L. Palmer, Ian Ganly · 2013 · Annals of Surgical Oncology
  92. Approach to the Patient with a Positive Serum Thyroglobulin and a Negative Radioiodine Scan after Initial Therapy for Differentiated Thyroid Cancer
    Richard T. Kloos · 2008 · The Journal of Clinical Endocrinology & Metabolism
  93. I-131 Activities as High as Safely Administrable (AHASA) for the Treatment of Children and Adolescents with Advanced Differentiated Thyroid Cancer
    Frederik A. Verburg, Johannes Biko, Stefanie Dießl · 2011 · The Journal of Clinical Endocrinology & Metabolism
  94. Serial TSH determination after T3 withdrawal or thyroidectomy in the therapy of thyroid carcinoma.
    S.V. Hilts, Dorothea E. Hellman, J Anderson, J.M. Woolfenden, J. Van Antwerp, Dennis D. Patton · 1979 · PubMed
  95. Familial nonmedullary thyroid carcinoma—clinical relevance and prognosis. A European multicenter study
    Andreas Hillenbrand, J E Varhaug, Michael Brauckhoff et al. · 2010 · Langenbeck s Archives of Surgery
  96. Radiopharmacokinetics of Radioiodine in the Parotid Glands After the Administration of Lemon Juice
    Douglas Van Nostrand, Varalakshmi V. Bandaru, Shyam P. Chennupati, Jason A. Wexler, Kanchan Kulkarni, Frank Atkins, Mihriye Mete, Gurudev Gadwale · 2010 · Thyroid
  97. The surgical management of goiter: Part I. preoperative evaluation
    Jennifer Joan Shin, Hermes C. Grillo, Doug Mathisen, Mark R. Katlic, David Zurakowski, Dipti Kamani, Gregory William Randolph · 2010 · The Laryngoscope
  98. Latin American Thyroid Society recommendations for the management of thyroid nodules
    R. Y. A. Camargo, Sandro M. Corigliano, Celso U. M. Friguglietti, Alicia Gauna, Rubén Harach, Fernando Munizaga, Hugo Nièpomniszcze, Fabián Pitoia, Eduardo A. Pretell, Mário Vaisman et al. · 2009 · Arquivos Brasileiros de Endocrinologia & Metabologia
  99. Factors That Predict Malignant Thyroid Lesions When Fine-Needle Aspiration Is “Suspicious for Follicular Neoplasm”
    Richard T. Schlinkert, Jon A. van Heerden, John R. Goellner · 1997 · Mayo Clinic Proceedings
  100. Does an undetectable rhTSH‐stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission?
    Joanna Kłubo-Gwieździńska, Kenneth Dale Burman, Douglas Van Nostrand, Leonard Wartofsky · 2010 · Clinical Endocrinology
  101. FN1, GALE, MET, and QPCT overexpression in papillary thyroid carcinoma: Molecular analysis using frozen tissue and routine fine‐needle aspiration biopsy samples
    Cristina Aparecida Troques da Silveira Mitteldorf, Juliana Moreira de Sousa-Canavez, Kátia Ramos Moreira Leite · 2010 · Diagnostic Cytopathology
  102. The Diagnostic Value of Calcitonin Measurement in Wash-out Fluid from Fine-Needle Aspiration of Thyroid Nodules in the Diagnosis of Medullary Thyroid Cancer
    Chiara Diazzi, Bruno Madeo, Erica Taliani et al. · 2013 · Endocrine Practice
  103. Ultrasonographic characteristics as a criterion for repeat cytology in benign thyroid nodules
    Pedro Weslley Rosário, Saulo Purisch · 2010 · Arquivos Brasileiros de Endocrinologia & Metabologia
  104. Papillary thyroid carcinoma: MR diagnosis of lymph node metastasis.
    Shodayu Takashima, Shusuke Sone, Fumiyoshi Takayama, Qian Wang, Tetsuro Kobayashi, Arata Horii, Junichi Yoshida · 1998 · PubMed Central
  105. Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer.
    JOSE MANUEL CARRIL, R. Quirce, Justo Serrano, Ignacio Banzo, Julio Francisco Jiménez-Bonilla, Olga Tabuenca, R Gómez Barquín · 1997 · PubMed
  106. The value of fine-needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds
    J. F. Hamming · 1990 · Archives of Internal Medicine
  107. Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma
    Schelto Kruijff, Ahmed M. Aniss, Paul Chen et al. · 2013 · Surgery
  108. Are there any specific ultrasound findings of nodular hyperplasia (“leave me alone” lesion) to differentiate it from follicular adenoma?
    Won‐Jin Moon, Hyon Joo Kwag, Dong-Gyu Na · 2009 · Acta Radiologica
  109. AACE/ACE Disease State Commentary: Molecular Diagnostic Testing of Thyroid Nodules with Indeterminate Cytopathology
    Victor Joseph Bernet, Kenneth H. Hupart, Sareh Parangi · 2014 · Endocrine Practice
  110. Is Empirical Radioactive Iodine Therapy Still a Valid Approach to Patients with Thyroid Cancer and Elevated Thyroglobulin?
    Pedro Weslley Rosário, Gabriela Franco Mourão, Juan Bernard Nascimento dos Santos · 2013 · Thyroid
  111. Optimal indication of thyroglobulin measurement in fine-needle aspiration for detecting lateral metastatic lymph nodes in patients with papillary thyroid carcinoma
    Jin Il Chung, Eun‐Kyung Kim, Hyunsun Lim, Eun Ju Son, Jung Hyun Yoon, Ji Hyun Youk, Jeong‐Ah Kim, Hee Jung Moon, Jin Young Kwak · 2013 · Head & Neck
  112. Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study
    Francoise Bonichon, Jean Palussière, Yann Godbert et al. · 2013 · European Journal of Nuclear Medicine and Molecular Imaging
  113. Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre
    Brian Hung‐Hin Lang, Chung‐Yau Lo, Wai-Fan Chan, King-Yin Lam, Koon Yat Wan · 2007 · Endocrine Related Cancer
  114. Clinical Significance of BRAF Mutation in Thyroid Papillary Cancer
    Ignacio Javier Fernandez, Ottavio Piccin, Silvia Sciascia · 2013 · Otolaryngology
  115. Serum thyroglobulin predicts thyroid remnant ablation failure with 30 mCi iodine-131 treatment in patients with papillary thyroid carcinoma
    Michael Tamilia, Nora S. Alkahtani, Louise Rochon · 2010 · Nuclear Medicine Communications
  116. Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience.
    Petros Perros · 1999 · PubMed
  117. High versus low radioiodine activity in patients with differentiated thyroid cancer: A meta-analysis
    Antonios Valachis, Andreas Demetrios Nearchou · 2012 · Acta Oncologica
  118. Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer
    Dimitris K Grammatopoulos, Y. Elliott, S C Smith, I Brown, Richard Grieve, E. W. Hillhouse, Michael A. Levine, Matthew David Ringel · 2003 · Molecular Pathology
  119. Is There a Role for Unstimulated Thyroglobulin Velocity in Predicting Recurrence in Papillary Thyroid Carcinoma Patients with Detectable Thyroglobulin after Radioiodine Ablation?
    Hilda Wong, Kai Pun Wong, Thomas C. C. Yau · 2012 · Annals of Surgical Oncology
  120. Prognostic Impact of Extrathyroid Extension and Clinical Lymph Node Metastasis in Papillary Thyroid Carcinoma Depend on Carcinoma Size
    Mitsuhiro Fukushima, Yasuhiro Ito, Mitsuyoshi Hirokawa, Akihiro Miya, Kazuo Shimizu, Akira Miyauchi · 2010 · World Journal of Surgery
  121. Recombinant human thyrotropin-aided versus thyroid hormone withdrawal-aided radioiodine treatment for differentiated thyroid cancer after total thyroidectomy: A meta-analysis
    Jian Tu, Siwen Wang, Siwen Wang · 2014 · Radiotherapy and Oncology
  122. Predictive Value of Recombinant Human TSH Stimulation and Neck Ultrasonography in Differentiated Thyroid Cancer Patients
    Umberto Crocetti, Cosimo Durante, Marco Attard et al. · 2008 · Thyroid
  123. Utility of the Radioiodine Whole-Body Retention at 48 Hours for Modifying Empiric Activity of 131-Iodine for the Treatment of Metastatic Well-Differentiated Thyroid Carcinoma
    Douglas Van Nostrand, Frank Atkins, Shari Moreau, Martha Aiken, Kanchan Kulkarni, Jingshu S. Wu, Kenneth Dale Burman, Leonard Wartofsky · 2009 · Thyroid
  124. Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer
    Ali Saeed Alzahrani, Gamal Mohamed, A. Al Shammary, Saleh A. Aldasouqi, Suzan Abdel Salam, Mohamed M. Shoukri · 2005 · Journal of Endocrinological Investigation
  125. Disease Severity and Radioactive Iodine Use for Thyroid Cancer
    Megan R. Haymart, Daniel G. Muenz, Andrew K. Stewart, Jennifer J. Griggs, Mousumi Banerjee · 2013 · The Journal of Clinical Endocrinology & Metabolism
  126. Sentinel Lymph Node Biopsy for Papillary Thyroid Cancer: 12 Years of Experience at a Single Institution
    Deborah K. Cunningham, Katherine A. Yao, Roderick R. Turner · 2010 · Annals of Surgical Oncology
  127. Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology
    Rohtesh S. Mehta, Sally E. Carty, N. Paul Ohori et al. · 2013 · Surgery
  128. Preparation of patients with thyroid cancer for 131I scintigraphy or therapy by 1-3 weeks of thyroxine discontinuation.
    Perry W. Grigsby, Barry Alan Siegel, Simon V. Bekker, William E. Clutter, Jeffrey F. Moley · 2004 · PubMed
  129. Comparison of I-123 and I-131 for Whole-Body Imaging After Stimulation by Recombinant Human Thyrotropin
    GREGORY S. ANDERSON, Stephanie A. Fish, Khozaim Nakhoda, Hongming Zhuang, Abass A. Alavi, Susan J. Mandel · 2003 · Clinical Nuclear Medicine
  130. Radioiodine Treatment of Thyroid Cancer with the Aid of Recombinant Human Thyrotropin
    Michael L. Adler, Homer A. Macapinlac, Richard J. Robbins · 1998 · Endocrine Practice
  131. Recurrent laryngeal nerve paralysis in patients with papillary thyroid carcinomas: evaluation and management of resulting vocal dysfunction
    Jong‐Lyel Roh, Yeo‐Hoon Yoon, Chan Il Park · 2008 · The American Journal of Surgery
  132. Maximal safe dose of I-131 after failure of standard fixed dose therapy in patients with differentiated thyroid carcinoma
    Jong Jin Lee, June-Key Chung, Sung Eun Kim, Won Jun Kang, Do Joon Park, Dong Soo Lee, Bo-Youn Cho, Myung Chul Lee · 2008 · Annals of Nuclear Medicine
  133. Levothyroxine Suppression of Thyroglobulin in Patients with Differentiated Thyroid Carcinoma1
    Pei‐Wen Wang, Shan‐Tair Wang, Rue‐Tsuan Liu, Wen-Yen Chien, Shih‐Chen Tung, Yung-Chuan Lu, Hue-Yong Chen, Chiang-Hsuan Lee · 1999 · The Journal of Clinical Endocrinology & Metabolism
  134. Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey
    Nathalie Bernard, Hélène Jantzem, Madlyne Becker, Caroline Pécriaux, Anne Bénard‐Laribière, Jean‐Louis Montastruc, Jacques Descotes, Thierry Vial · 2015 · BJOG An International Journal of Obstetrics & Gynaecology
  135. Thyroid tumor marker genomics and proteomics: Diagnostic and clinical implications
    Angelo Carpi, Jeffrey Ian Mechanick, Sven Saussez, Andrea Nicolini · 2010 · Journal of Cellular Physiology
  136. Same-day ultrasound guidance in reoperation for locally recurrent papillary thyroid cancer
    Kelly L. McCoy, John Hosei Yim, MITCHELL E. TUBLIN · 2007 · Surgery
  137. Recurrent laryngeal nerve dysfunction following carotid endarterectomy.
    A. Curran, David R. Smyth, S. Sheehan · 1997 · PubMed
  138. Evaluation of Postoperative Radioactive Iodine Scans in Patients who Underwent Prophylactic Central Lymph Node Dissection
    Amanda M. Laird, Paul G. Gauger, Barbra S. Miller · 2012 · World Journal of Surgery
  139. Treatment of iodine-negative thyroglobulin-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases
    Levent Kabasakal, Nalan Alan Selçuk, Hojjet Shafipour, Özlem Özmen, Çetin Önsel, İlhami Uslu · 2004 · European Journal of Nuclear Medicine and Molecular Imaging
  140. GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma
    Jean‐Philippe Spano, Y-A. Vano, Stéphane Vignot, Thibault De La Motte Rouge, Lamia Hassani, Roger Mouawad, F. Ménégaux, David Khayat, Laurence Leenhardt · 2011 · Medical Oncology
  141. Papillary Thyroid Carcinoma Patients Assessed to Be at Low or Intermediary Risk After Primary Treatment Are at Greater Risk of Long Term Recurrence If They Are Thyroglobulin Antibody Positive Or Do Not Have Distinctly Low Thyroglobulin at Initial Assessment
    Özlem Soyluk, Harika Boztepe, Ferihan Aral · 2011 · Thyroid
  142. Influence of age and primary tumor size on the risk for residual/recurrent well‐differentiated thyroid carcinoma
    Steven Orlov, David Orlov, Michael Shaytzag · 2009 · Head & Neck
  143. Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer
    Chao Ma, Jiawei Xie, Wanxia Liu, Guo‐Ming Wang, Shuyao Zuo, Xufu Wang, Fengyu Wu · 2010 · Cochrane Database of Systematic Reviews
  144. L‐T<sub>3</sub> preparation for whole‐body scintigraphy: a randomized‐controlled trial
    Leboeuf, Rébecca, Perron, Patrice, Carpentier, André C., Verreault, Jean, Langlois, Marie‐France · 2007 · Clinical Endocrinology
  145. Update in Utility of Secondary Node Dissection for Papillary Thyroid Cancer
    David L. Steward · 2012 · The Journal of Clinical Endocrinology & Metabolism
  146. What Are Thyroidectomy Patients Really Concerned About?
    Lara Abdul‐Sater, Mélissa Henry, Agnieszka Majdan, Tamara Mijović, Jason H. Franklin, Michael G. Brandt, Martin J. Black, Michael Hier, Richard J. Payne · 2011 · Otolaryngology
  147. Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches
    Pamela Jo Harris, Keith Christopher Bible · 2011 · Expert Opinion on Investigational Drugs
  148. Treatment of Scan-Negative, Thyroglobulin-Positive Metastatic Thyroid Cancer Using Radioiodine 131I and Recombinant Human Thyroid Stimulating Hormone
    A. Z. Rudavsky · 1997 · The Journal of Clinical Endocrinology & Metabolism
  149. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
    Barbara Salvatore, Gaetano Paone, Michele Klain, Giovanni Storto, Emanuele Nicolai, Domenico D’Amico, Anna Maria Della Morte, Leonardo Pace, Marco Salvatore · 2008 · PubMed
  150. Risk stratification of patients with locally aggressive differentiated thyroid cancer
    J. A. Krämer, K. W. Schmid, Henning Dralle · 2010 · Nuklearmedizin - NuclearMedicine
  151. Moral Wounds: Complicated Complications
    Shari Munch, L. L. Dekryger · 2001 · JAMA
  152. Gonadal damage from 131I therapy for thyroid cancer
    Ernest L. Mazzaferri · 2002 · Clinical Endocrinology
  153. Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma
    Reverter, Jordi L., Colomé, Eulàlia, Holgado, Susana, Aguilera, Eva, Soldevila, Berta, Mateo, Lourdes, Sanmartí, Anna · 2010 · Endocrine
  154. Assessment of molecular testing in fine-needle aspiration biopsy samples: An experience in a Chinese population
    Shu Liu, Aibo Gao, Bingfei Zhang, Zhaoxia Zhang, Yanru Zhao, Pu Chen, Meiju Ji, Peng Hou, Bingyin Shi · 2014 · Experimental and Molecular Pathology
  155. Familial nonmedullary thyroid carcinoma
    Carl D. Malchoff, Diana Mark Malchoff · 1999 · Seminars in Surgical Oncology
  156. Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer
    Ali Saeed Alzahrani, Hussein Raef, A. Sultan · 2002 · Journal of Endocrinological Investigation
  157. Is Above Age 45 Appropriate for Upstaging Well-Differentiated Papillary Thyroid Cancer?
    Lindsay A. Bischoff, Joseph Curry, Intekhab Ahmed · 2013 · Endocrine Practice
  158. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma
    Luca Giovanella, Marco Maffioli, Luca Ceriani · 2009 · Clinical Chemistry and Laboratory Medicine (CCLM)
  159. 99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer
    Domenico Rubello, Massimo Salvatori, Dario Casara, Andrea Piotto, Antonio Toniato, Milton D. Gross, ADIL M. AL-NAHHAS, P. C. Muzzio, Maria Rosa Pelizzo · 2007 · European Journal of Surgical Oncology
  160. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
    Cheng‐Hsiung Chen, Jung‐Fu Chen, Bor-Yan Yang, Rue‐Tsuan Liu, Shih‐Chen Tung, Wen‐Yen Chien, Yung‐Chuan Lu, Ming‐Chun Kuo, Ching‐Jung Hsieh, Pei‐Wen Wang · 2004 · PubMed
  161. Determining the appropriate time of execution of an I-131 post-therapy whole-body scan
    Massimo Salvatori, Germano Perotti, Maria Felicia Villani · 2013 · Nuclear Medicine Communications
  162. Cystic Lymph Nodes in the Lateral Neck As Indicators of Metastatic Papillary Thyroid Cancer
    Christine S. Landry, Elizabeth Gardner Grubbs, Naifa Lamki Busaidy · 2010 · Endocrine Practice
  163. HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules
    Paul J. Lappinga, Nefize Sertac Kip, Long Guo Jin, Ricardo V. Lloyd, Michael R. Henry, Jun Zhang, Aziza Nassar · 2010 · Cancer Cytopathology
  164. Impact of Initial Surgical Treatment on Survival of Patients with Differentiated Thyroid Cancer: Experience of an Endocrine Surgery Center in an Iodine‐deficient Region
    Mete Düren, Nihat Yavuz, Yusuf Bükey, Mustafa Ates Ozyegin, Sadi Gündoğdu, Özer Açbay, Husrey Hatemi, Ihami Uslu, Çetin Önsel, Figen Aksoy et al. · 2000 · World Journal of Surgery
  165. Post-operative neck ultrasound and risk stratification in differentiated thyroid cancer patients with initial lymph node involvement
    Charlotte Lussey‐Lepoutre, Dina Maddah, Jean‐Louis Golmard · 2014 · European Journal of Endocrinology
  166. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma
    Kien T. Mai, Priya Khanna, Hossein M. Yazdi, D. Garth Perkins, John P. Veinot, Jane Thomas, Manisha Lamba, Bhavani D. Nair · 2002 · Pathology
  167. Sudden Enlargement of Local Recurrent Thyroid Tumor after Recombinant Human TSH Administration
    Milena Braga · 2001 · The Journal of Clinical Endocrinology & Metabolism
  168. BRAF Status of Follicular Variant of Papillary Thyroid Carcinoma and its Relationship to Its Clinical and Cytological Features
    Agnese Proietti, Riccardo Giannini, Clara Ugolini · 2010 · Thyroid
  169. Clinical applications of SPECT / CT after first I‐131 ablation in patients with differentiated thyroid cancer
    Shin Young Jeong, Sang‐Woo Lee, Hae Won Kim · 2014 · Clinical Endocrinology
  170. Osteoporosis and Thyrotropin-Suppressive Therapy: Reduced Effectiveness of Alendronate
    Annalisa Panico, Giovanni Lupoli, Francesco Fonderico, Francesca Marciello, Addolorata Martinelli, Roberta Assante, Giovanni Lupoli · 2009 · Thyroid
  171. The 2009 American Thyroid Association Guidelines for Management of Thyroid Nodules and Differentiated Thyroid Cancer: Progress on the Road from Consensus- to Evidence-Based Practice
    Efisio Puxeddu, Sébastiano Filetti · 2009 · Thyroid
  172. Adjuvant Radioactive Therapy after Reoperation for Locoregionally Recurrent Papillary Thyroid Cancer in Patients Who Initially Underwent Total Thyroidectomy and High-Dose Remnant Ablation
    Ji Hye Yim, Won Bae Kim, Eui Young Kim et al. · 2011 · The Journal of Clinical Endocrinology & Metabolism
  173. Thyroxine Suppression Therapy For Benign, Non-Functioning Solitary Thyroid Nodules: A Quality-Effects Meta-Analysis
    Altayyeb Yousef, Justin Michael Clark, Suhail A.R. Doi · 2010 · Clinical Medicine & Research
  174. Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma.
    M Marchesi, Marco Biffoni, Fausto Biancari, Alberto Berni, Francesco Paolo Campana · 2003 · PubMed
  175. [Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data].
    M R Pelizzo, Isabella Merante Boschin, Antonio Toniato · 2007 · PubMed
  176. Salivary Gland Malignancy and Radioiodine Therapy for Thyroid Cancer
    Joanna Kłubo-Gwieździńska, Douglas Van Nostrand, Kenneth Dale Burman · 2010 · Thyroid
  177. Patient satisfaction with decision-making for breast cancer therapy
    Stephen Marshall Weiss, Paul A. Wengert, Eduardo Martínez · 1996 · Annals of Surgical Oncology
  178. Patient decision aids for cancer treatment
    Gillian Spiegle, Eisar Al‐Sukhni, Selina Schmocker · 2012 · Cancer
  179. Highlights of the American Thyroid Association Guidelines for Patients with Thyroid Nodules or Differentiated Thyroid Carcinoma: The 2009 Revision
    Leonard Wartofsky · 2009 · Thyroid
  180. Predictors of Level II and Vb Neck Disease in Metastatic Papillary Thyroid Cancer
    Mazin A. Merdad, Antoine E. Eskander, Teresa R. Kroeker · 2012 · Archives of Otolaryngology - Head and Neck Surgery
  181. Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy
    W. F. E. Lau, Margaret Zacharin, Karen Ann Waters, Greg Wheeler, V. K. Johnston, Rodney J. Hicks · 2006 · Internal Medicine Journal
  182. The Nonimpact of Thyroid Stunning: Remnant Ablation Rates in 131I-Scanned and Nonscanned Individuals
    Lilah F. Morris · 2001 · The Journal of Clinical Endocrinology & Metabolism
  183. Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism
    Matthew David Ringel · 1996 · The Journal of Clinical Endocrinology & Metabolism
  184. Sequential Follow-up of Serum Thyroglobulin and Whole Body Scan in Thyroid Cancer Patients without Initial Metastasis
    Huang, Shu-Hua, Wang, Pei-Wen, Huang, Yu-Erh, Chou, Fong-Fu, Liu, Rue-Tsuan, Tung, Shih-Chen, Chen, Jung-Fu, Kuo, Ming-Chun, Hsieh, Jing-Rong, Hsieh, Hsin-Hung · 2006 · Thyroid
  185. Metastatic Thyroid Cancer Unresponsive to Conventional Therapies: Novel Management Approaches Through Translational Clinical Research
    Nicholas J. Sarlis · 2001 · Current Drug Targets - Immune Endocrine & Metabolic Disorders
  186. Preoperative FDG‐PET imaging to assess the malignant potential of follicular neoplasms of the thyroid
    Russell B. Smith, Robert Anthony Robinson, Henry T. Hoffman · 2008 · Otolaryngology
  187. Adequate Thyroid-Stimulating Hormone Levels After Levothyroxine Discontinuation in the Follow-Up of Patients with Well-Differentiated Thyroid Carcinoma
    R Velasco Sánchez, Ana Laura Espinosa-de-los-Monteros, Victoria Mendoza, Eduardo Brea, Irma Hernández, Ernesto Sosa, Moisés Mercado · 2002 · Archives of Medical Research
  188. Authors’ Response: A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma
    Ernest L. Mazzaferri, Richard J. Robbins, Lewis E. Braverman, Furio Pacini, Bryan R. Haugen, Leonard Wartofsky, Glenn David Braunstein, Paul W. Ladenson, Aldo Pinchera · 2003 · The Journal of Clinical Endocrinology & Metabolism
  189. Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal.
    Wim J.G. Oyen, C Verhagen, E Saris, W J van den Broek, GERHARD F. F. M. PIETERS, F H Corsten · 2000 · PubMed
  190. Follicular lesions of the thyroid: A retrospective study of 1,348 fine needle aspiration biopsies
    Shoujin Wu, Richard M. DeMay, Pamela Papas · 2010 · Diagnostic Cytopathology
  191. Persistent Posttreatment Fatigue in Thyroid Cancer Survivors
    Anna M. Sawka, Asima Naeem, Jennifer Michelle Jones, Julia M. LOWE, Philip Segal, Jeannette Goguen, Jeremy D. Gilbert, Afshan Zahedi, Catherine Margaret Kelly, Shereen Ezzat · 2014 · Endocrinology and Metabolism Clinics of North America
  192. Possible reasons for different pattern disappearance of thyroglobulin and thyroid peroxidase autoantibodies in patients with differentiated thyroid carcinoma following total thyroidectomy and iodine-131 ablation
    Dimitrios Thomas, V Liakos, E Vassiliou, F. Hatzimarkou, Agathocles A. Tsatsoulis, Philippos Kaldrimides · 2007 · Journal of Endocrinological Investigation
  193. Lobe ablation with radioactive iodine as an alternative to completion thyroidectomy after hemithyroidectomy in patients with follicular thyroid cancer: long-term follow-up.
    Giuseppe Barbesino, Melanie R. Goldfarb, Sareh Parangi, Jingyun Yang, Douglas S. Ross, Gilbert H. Daniels · 2011 · Thyroid
  194. Serum thyroglobulin in patients undergoing subtotal thyroidectomy for toxic and nontoxic goiter
    Ulla Feldt‐Rasmussen, P H Petersen, John Date, Charlotte Madsen · 1982 · Journal of Endocrinological Investigation
  195. Positive Predictive Value of Detectable Stimulated Tg During the First Year After Therapy of Thyroid Cancer and the Value of Comparison with Tg-Ablation and Tg Measured After 24 Months
    Maristane Mendes Andrade Valadão, Pedro Weslley Rosário, Michelle Aparecida Ribeiro Borges · 2006 · Thyroid
  196. Thyroid incidentalomas: to treat or not to treat
    Narayanan Gopalakrishna Iyer, Ashok R. Shaha, Carl E. Silver · 2010 · European Archives of Oto-Rhino-Laryngology
  197. Report of an International Survey of Molecular Genetic Testing Laboratories
    Margaret M. McGovern, Rob Elles, Isabella Beretta, Martin J. Somerville, Gerald Höefler, Mauri Keinänen, David E. Barton, Nancy L. Carson, Elisabeth M. C. Dequeker, R Brdička et al. · 2007 · Public Health Genomics
  198. Adjuvant thyroid remnant ablation in patients with differentiated thyroid carcinoma confined to the thyroid: a comparison of ablation success with different activities of radioiodine (I-131)
    Marin Prpić, Nina Dabelić, Josip Staničić · 2012 · Annals of Nuclear Medicine
  199. Fine-Needle Aspiration Biopsy: Use in Diagnosis and Management of Pediatric Thyroid Diseases
    Hossein Gharib, Donald Zimmerman, John R. Goellner, Sheryl M. Bridley, Suzanne M. LeBlanc · 1995 · Endocrine Practice
  200. Levothyroxine Suppression of Thyroglobulin in Patients with Differentiated Thyroid Carcinoma
    P.-W. Wang · 1999 · The Journal of Clinical Endocrinology & Metabolism